NCT04499755

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics: A Randomized Controlled Trial

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Sherief Abd-Elsalam · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Detailed description

The study aims to study the Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Conditions

• Brain Injuries

Interventions

Type	Name	Description
DRUG	Nucleo CMP Forte	Nucleo CMP Forte twice daily for 6 weeks

Timeline

• Start date: 2020-06-01
• Primary completion: 2030-12-01
• Completion: 2030-12-10
• First posted: 2020-08-05
• Last updated: 2020-08-05

Locations

1 site across 1 country: Egypt